Details for Patent: 5,296,504
✉ Email this page to a colleague
Summary for Patent: 5,296,504
Title: | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
Abstract: | The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension. |
Inventor(s): | Stjernschantz; Johan W. (Uppsala, SE), Resul; Bahram (Uppsala, SE) |
Assignee: | Kabi Pharmacia (SE) |
Application Number: | 07/987,520 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 5,296,504
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,296,504
International Family Members for US Patent 5,296,504
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 101342 | ⤷ Try a Trial | |||
Austria | 227576 | ⤷ Try a Trial | |||
Austria | 420857 | ⤷ Try a Trial | |||
Australia | 4189889 | ⤷ Try a Trial | |||
Australia | 625096 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |